Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.
Savic RM, Weiner M, MacKenzie WR, Engle M, Whitworth WC, Johnson JL, Nsubuga P, Nahid P, Nguyen NV, Peloquin CA, Dooley KE, Dorman SE; Tuberculosis Trials Consortium of the Centers for Disease Control and Prevention. Savic RM, et al. Among authors: MacKenzie WR. Version 2. Clin Pharmacol Ther. 2017 Aug;102(2):321-331. doi: 10.1002/cpt.634. Epub 2017 Mar 2. Clin Pharmacol Ther. 2017. PMID: 28124478 Free PMC article. Clinical Trial.
Seasonality of tuberculosis in the United States, 1993-2008.
Willis MD, Winston CA, Heilig CM, Cain KP, Walter ND, Mac Kenzie WR. Willis MD, et al. Clin Infect Dis. 2012 Jun;54(11):1553-60. doi: 10.1093/cid/cis235. Epub 2012 Apr 3. Clin Infect Dis. 2012. PMID: 22474225 Free PMC article.
Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.
Weiner M, Egelund EF, Engle M, Kiser M, Prihoda TJ, Gelfond JA, Mac Kenzie W, Peloquin CA. Weiner M, et al. J Antimicrob Chemother. 2014 Apr;69(4):1079-85. doi: 10.1093/jac/dkt483. Epub 2013 Dec 15. J Antimicrob Chemother. 2014. PMID: 24343893 Free PMC article. Clinical Trial.
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
Dorman SE, Savic RM, Goldberg S, Stout JE, Schluger N, Muzanyi G, Johnson JL, Nahid P, Hecker EJ, Heilig CM, Bozeman L, Feng PJ, Moro RN, MacKenzie W, Dooley KE, Nuermberger EL, Vernon A, Weiner M; Tuberculosis Trials Consortium. Dorman SE, et al. Among authors: MacKenzie W. Am J Respir Crit Care Med. 2015 Feb 1;191(3):333-43. doi: 10.1164/rccm.201410-1843OC. Am J Respir Crit Care Med. 2015. PMID: 25489785 Free PMC article. Clinical Trial.
Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.
Jayakumar A, Vittinghoff E, Segal MR, MacKenzie WR, Johnson JL, Gitta P, Saukkonen J, Anderson J, Weiner M, Engle M, Yoon C, Kato-Maeda M, Nahid P; Tuberculosis Trials Consortium. Jayakumar A, et al. Among authors: MacKenzie WR. Tuberculosis (Edinb). 2015 Jul;95(4):415-20. doi: 10.1016/j.tube.2015.04.011. Epub 2015 May 9. Tuberculosis (Edinb). 2015. PMID: 26022314 Free PMC article. Clinical Trial.
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.
Shepardson D, Marks SM, Chesson H, Kerrigan A, Holland DP, Scott N, Tian X, Borisov AS, Shang N, Heilig CM, Sterling TR, Villarino ME, Mac Kenzie WR. Shepardson D, et al. Int J Tuberc Lung Dis. 2013 Dec;17(12):1531-7. doi: 10.5588/ijtld.13.0423. Int J Tuberc Lung Dis. 2013. PMID: 24200264 Free PMC article.
Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa.
Mac Kenzie WR, Heilig CM, Bozeman L, Johnson JL, Muzanye G, Dunbar D, Jost KC Jr, Diem L, Metchock B, Eisenach K, Dorman S, Goldberg S. Mac Kenzie WR, et al. PLoS One. 2011 Apr 11;6(4):e18358. doi: 10.1371/journal.pone.0018358. PLoS One. 2011. PMID: 21494548 Free PMC article. Clinical Trial.
20 results
Jump to page
Feedback